Findings from research collaboration with Brock University also show improved function in metabolic area and skeletal and cardiac muscle. LONDON, Sept. 19, 2023 /PRNewswire/ -- AMO Pharma Limited ...

Researchers also reported results from a separate trial of a gene therapy the company is developing for PKP2-related arrhythmogenic cardiomyopathy.

New research shows how muscular dystrophy (DM1) damages the heart over time, stressing the need for early diagnosis and ...